nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—UGT1A1—Etoposide—peripheral nervous system neoplasm	0.127	1	CbGbCtD
Testosterone Propionate—CYP17A1—Androgen biosynthesis—HSD17B12—peripheral nervous system neoplasm	0.0302	0.223	CbGpPWpGaD
Testosterone Propionate—COMT—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—peripheral nervous system neoplasm	0.0151	0.111	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of steroid hormones and vitamin D—HSD17B12—peripheral nervous system neoplasm	0.0126	0.0924	CbGpPWpGaD
Testosterone Propionate—COMT—Dopamine metabolism—TH—peripheral nervous system neoplasm	0.00961	0.0708	CbGpPWpGaD
Testosterone Propionate—COMT—Biogenic Amine Synthesis—TH—peripheral nervous system neoplasm	0.00857	0.0631	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.0068	0.0501	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.00577	0.0425	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00337	0.0248	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—COX2—peripheral nervous system neoplasm	0.0029	0.0214	CbGpPWpGaD
Testosterone Propionate—Drospirenone—BCHE—peripheral nervous system neoplasm	0.00228	0.405	CrCbGaD
Testosterone Propionate—UGT1A1—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.00224	0.0165	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	0.00223	0.0164	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—IFNB1—peripheral nervous system neoplasm	0.00151	0.0111	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.0015	0.0111	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.00138	0.0101	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00129	0.00947	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.00115	0.00845	CbGpPWpGaD
Testosterone Propionate—Megestrol acetate—ABCB1—peripheral nervous system neoplasm	0.00102	0.182	CrCbGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.000995	0.00732	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000969	0.00713	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000889	0.00655	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000888	0.00654	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000886	0.00652	CbGpPWpGaD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CDKN2A—peripheral nervous system neoplasm	0.000882	0.00649	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00088	0.00647	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000848	0.00625	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000844	0.00621	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000815	0.00111	CcSEcCtD
Testosterone Propionate—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000815	0.00111	CcSEcCtD
Testosterone Propionate—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000814	0.00111	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000812	0.00111	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000808	0.0011	CcSEcCtD
Testosterone Propionate—Oedema—Vincristine—peripheral nervous system neoplasm	0.000808	0.0011	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—HRAS—peripheral nervous system neoplasm	0.000807	0.00594	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000805	0.0011	CcSEcCtD
Testosterone Propionate—Asthenia—Topotecan—peripheral nervous system neoplasm	0.0008	0.00109	CcSEcCtD
Testosterone Propionate—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.000795	0.00109	CcSEcCtD
Testosterone Propionate—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000794	0.00109	CcSEcCtD
Testosterone Propionate—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000794	0.00109	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000792	0.00108	CcSEcCtD
Testosterone Propionate—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00079	0.00108	CcSEcCtD
Testosterone Propionate—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000789	0.00108	CcSEcCtD
Testosterone Propionate—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000784	0.00107	CcSEcCtD
Testosterone Propionate—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000783	0.00107	CcSEcCtD
Testosterone Propionate—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000783	0.00107	CcSEcCtD
Testosterone Propionate—Dermatitis bullous—Epirubicin—peripheral nervous system neoplasm	0.000781	0.00107	CcSEcCtD
Testosterone Propionate—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00078	0.00107	CcSEcCtD
Testosterone Propionate—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000773	0.00106	CcSEcCtD
Testosterone Propionate—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000773	0.00106	CcSEcCtD
Testosterone Propionate—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000771	0.00105	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000764	0.00104	CcSEcCtD
Testosterone Propionate—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000763	0.00104	CcSEcCtD
Testosterone Propionate—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000758	0.00104	CcSEcCtD
Testosterone Propionate—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000757	0.00104	CcSEcCtD
Testosterone Propionate—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000757	0.00104	CcSEcCtD
Testosterone Propionate—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000753	0.00103	CcSEcCtD
Testosterone Propionate—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000748	0.00102	CcSEcCtD
Testosterone Propionate—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000747	0.00102	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000747	0.00102	CcSEcCtD
Testosterone Propionate—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000745	0.00102	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000745	0.00102	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000744	0.00102	CcSEcCtD
Testosterone Propionate—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000743	0.00102	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00074	0.00101	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00074	0.00101	CcSEcCtD
Testosterone Propionate—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000738	0.00101	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000737	0.00543	CbGpPWpGaD
Testosterone Propionate—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000736	0.00101	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000736	0.00101	CcSEcCtD
Testosterone Propionate—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000735	0.00101	CcSEcCtD
Testosterone Propionate—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000732	0.001	CcSEcCtD
Testosterone Propionate—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000732	0.001	CcSEcCtD
Testosterone Propionate—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000731	0.000999	CcSEcCtD
Testosterone Propionate—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000726	0.000992	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000724	0.00099	CcSEcCtD
Testosterone Propionate—Malaise—Etoposide—peripheral nervous system neoplasm	0.000723	0.000989	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000723	0.00532	CbGpPWpGaD
Testosterone Propionate—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000723	0.000989	CcSEcCtD
Testosterone Propionate—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.000723	0.000988	CcSEcCtD
Testosterone Propionate—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000717	0.000981	CcSEcCtD
Testosterone Propionate—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000715	0.000978	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000715	0.000977	CcSEcCtD
Testosterone Propionate—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000715	0.000977	CcSEcCtD
Testosterone Propionate—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000714	0.000976	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—AKT1—peripheral nervous system neoplasm	0.000713	0.00525	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—peripheral nervous system neoplasm	0.00071	0.00523	CbGpPWpGaD
Testosterone Propionate—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000709	0.00097	CcSEcCtD
Testosterone Propionate—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000704	0.000962	CcSEcCtD
Testosterone Propionate—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000704	0.000962	CcSEcCtD
Testosterone Propionate—Rash—Topotecan—peripheral nervous system neoplasm	0.000703	0.000962	CcSEcCtD
Testosterone Propionate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000703	0.000961	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000701	0.000958	CcSEcCtD
Testosterone Propionate—Headache—Topotecan—peripheral nervous system neoplasm	0.000699	0.000955	CcSEcCtD
Testosterone Propionate—Rash—Tretinoin—peripheral nervous system neoplasm	0.000698	0.000954	CcSEcCtD
Testosterone Propionate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000698	0.000954	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000698	0.000954	CcSEcCtD
Testosterone Propionate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000697	0.000953	CcSEcCtD
Testosterone Propionate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000697	0.000953	CcSEcCtD
Testosterone Propionate—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000697	0.000953	CcSEcCtD
Testosterone Propionate—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000694	0.00095	CcSEcCtD
Testosterone Propionate—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000694	0.000949	CcSEcCtD
Testosterone Propionate—Headache—Tretinoin—peripheral nervous system neoplasm	0.000693	0.000948	CcSEcCtD
Testosterone Propionate—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000693	0.000948	CcSEcCtD
Testosterone Propionate—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000692	0.000947	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000691	0.000945	CcSEcCtD
Testosterone Propionate—Pain—Vincristine—peripheral nervous system neoplasm	0.000691	0.000945	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000691	0.000945	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000689	0.000942	CcSEcCtD
Testosterone Propionate—Rash—Melphalan—peripheral nervous system neoplasm	0.000689	0.000942	CcSEcCtD
Testosterone Propionate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000688	0.000941	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000686	0.000938	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000678	0.000927	CcSEcCtD
Testosterone Propionate—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000675	0.000922	CcSEcCtD
Testosterone Propionate—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000675	0.000922	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000672	0.00495	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000666	0.000911	CcSEcCtD
Testosterone Propionate—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000666	0.000911	CcSEcCtD
Testosterone Propionate—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000663	0.000906	CcSEcCtD
Testosterone Propionate—Nausea—Topotecan—peripheral nervous system neoplasm	0.000663	0.000906	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000661	0.000904	CcSEcCtD
Testosterone Propionate—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00066	0.000902	CcSEcCtD
Testosterone Propionate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000657	0.000899	CcSEcCtD
Testosterone Propionate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000657	0.000899	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000655	0.000895	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000651	0.00089	CcSEcCtD
Testosterone Propionate—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000649	0.000887	CcSEcCtD
Testosterone Propionate—Nausea—Melphalan—peripheral nervous system neoplasm	0.000649	0.000887	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000647	0.00476	CbGpPWpGaD
Testosterone Propionate—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000642	0.000877	CcSEcCtD
Testosterone Propionate—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000639	0.000873	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000638	0.000872	CcSEcCtD
Testosterone Propionate—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000637	0.000871	CcSEcCtD
Testosterone Propionate—Spironolactone—ABCB1—peripheral nervous system neoplasm	0.000637	0.113	CrCbGaD
Testosterone Propionate—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000636	0.000869	CcSEcCtD
Testosterone Propionate—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000624	0.000854	CcSEcCtD
Testosterone Propionate—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000619	0.000846	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000618	0.000845	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000617	0.000843	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000615	0.00453	CbGpPWpGaD
Testosterone Propionate—Pain—Cisplatin—peripheral nervous system neoplasm	0.000611	0.000835	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000605	0.00445	CbGpPWpGaD
Testosterone Propionate—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000603	0.000825	CcSEcCtD
Testosterone Propionate—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000602	0.000823	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000598	0.00441	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000595	0.000814	CcSEcCtD
Testosterone Propionate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000593	0.000811	CcSEcCtD
Testosterone Propionate—Norethindrone—ABCB1—peripheral nervous system neoplasm	0.000591	0.105	CrCbGaD
Testosterone Propionate—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000589	0.000805	CcSEcCtD
Testosterone Propionate—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000588	0.000804	CcSEcCtD
Testosterone Propionate—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000587	0.000803	CcSEcCtD
Testosterone Propionate—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000584	0.000798	CcSEcCtD
Testosterone Propionate—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00058	0.000793	CcSEcCtD
Testosterone Propionate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000575	0.000786	CcSEcCtD
Testosterone Propionate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000574	0.000785	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000573	0.00422	CbGpPWpGaD
Testosterone Propionate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00057	0.00078	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000565	0.000773	CcSEcCtD
Testosterone Propionate—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000564	0.000772	CcSEcCtD
Testosterone Propionate—Pain—Etoposide—peripheral nervous system neoplasm	0.00056	0.000765	CcSEcCtD
Testosterone Propionate—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000558	0.000763	CcSEcCtD
Testosterone Propionate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000555	0.000758	CcSEcCtD
Testosterone Propionate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000553	0.000756	CcSEcCtD
Testosterone Propionate—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000549	0.00075	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000544	0.000744	CcSEcCtD
Testosterone Propionate—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000543	0.000743	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000539	0.000738	CcSEcCtD
Testosterone Propionate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000537	0.000735	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000535	0.000732	CcSEcCtD
Testosterone Propionate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000534	0.000731	CcSEcCtD
Testosterone Propionate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000533	0.000729	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000531	0.00391	CbGpPWpGaD
Testosterone Propionate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000529	0.000723	CcSEcCtD
Testosterone Propionate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000528	0.000722	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000526	0.00072	CcSEcCtD
Testosterone Propionate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000525	0.000718	CcSEcCtD
Testosterone Propionate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00052	0.000711	CcSEcCtD
Testosterone Propionate—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000519	0.00071	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—EED—peripheral nervous system neoplasm	0.000519	0.00382	CbGpPWpGaD
Testosterone Propionate—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000517	0.000708	CcSEcCtD
Testosterone Propionate—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000516	0.000706	CcSEcCtD
Testosterone Propionate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000514	0.000703	CcSEcCtD
Testosterone Propionate—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000513	0.000701	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.00051	0.000697	CcSEcCtD
Testosterone Propionate—Rash—Vincristine—peripheral nervous system neoplasm	0.00051	0.000697	CcSEcCtD
Testosterone Propionate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000509	0.000696	CcSEcCtD
Testosterone Propionate—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000508	0.000694	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000508	0.000694	CcSEcCtD
Testosterone Propionate—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000506	0.000692	CcSEcCtD
Testosterone Propionate—Headache—Vincristine—peripheral nervous system neoplasm	0.000506	0.000692	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000503	0.000688	CcSEcCtD
Testosterone Propionate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000498	0.000681	CcSEcCtD
Testosterone Propionate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000489	0.000668	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000482	0.000659	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—peripheral nervous system neoplasm	0.000481	0.00354	CbGpPWpGaD
Testosterone Propionate—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.00048	0.000657	CcSEcCtD
Testosterone Propionate—Nausea—Vincristine—peripheral nervous system neoplasm	0.00048	0.000656	CcSEcCtD
Testosterone Propionate—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000478	0.000653	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	0.000477	0.00351	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000476	0.00351	CbGpPWpGaD
Testosterone Propionate—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000472	0.000645	CcSEcCtD
Testosterone Propionate—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00047	0.000642	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.00047	0.000642	CcSEcCtD
Testosterone Propionate—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000469	0.000641	CcSEcCtD
Testosterone Propionate—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000468	0.000641	CcSEcCtD
Testosterone Propionate—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000467	0.000638	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000465	0.000636	CcSEcCtD
Testosterone Propionate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000463	0.000633	CcSEcCtD
Testosterone Propionate—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000456	0.000624	CcSEcCtD
Testosterone Propionate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000454	0.000621	CcSEcCtD
Testosterone Propionate—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000452	0.000619	CcSEcCtD
Testosterone Propionate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000451	0.000616	CcSEcCtD
Testosterone Propionate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00045	0.000615	CcSEcCtD
Testosterone Propionate—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.00045	0.000615	CcSEcCtD
Testosterone Propionate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000448	0.000612	CcSEcCtD
Testosterone Propionate—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000434	0.000593	CcSEcCtD
Testosterone Propionate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000433	0.000592	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—GNS—peripheral nervous system neoplasm	0.000433	0.00319	CbGpPWpGaD
Testosterone Propionate—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000432	0.00059	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000431	0.000589	CcSEcCtD
Testosterone Propionate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000424	0.00058	CcSEcCtD
Testosterone Propionate—Hydrocortisone—ABCB1—peripheral nervous system neoplasm	0.000423	0.0751	CrCbGaD
Testosterone Propionate—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000422	0.000577	CcSEcCtD
Testosterone Propionate—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000419	0.000572	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000417	0.00057	CcSEcCtD
Testosterone Propionate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000416	0.000569	CcSEcCtD
Testosterone Propionate—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000416	0.000569	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000415	0.00305	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—NME1—peripheral nervous system neoplasm	0.000415	0.00305	CbGpPWpGaD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—AKT1—peripheral nervous system neoplasm	0.000415	0.00305	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GNS—peripheral nervous system neoplasm	0.000414	0.00305	CbGpPWpGaD
Testosterone Propionate—Rash—Etoposide—peripheral nervous system neoplasm	0.000413	0.000564	CcSEcCtD
Testosterone Propionate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000412	0.000564	CcSEcCtD
Testosterone Propionate—Headache—Etoposide—peripheral nervous system neoplasm	0.00041	0.000561	CcSEcCtD
Testosterone Propionate—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000405	0.000554	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—COX2—peripheral nervous system neoplasm	0.000399	0.00294	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—NME1—peripheral nervous system neoplasm	0.000397	0.00292	CbGpPWpGaD
Testosterone Propionate—Nausea—Etoposide—peripheral nervous system neoplasm	0.000389	0.000532	CcSEcCtD
Testosterone Propionate—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000388	0.000531	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.000528	CcSEcCtD
Testosterone Propionate—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000383	0.000523	CcSEcCtD
Testosterone Propionate—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000383	0.000523	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—COX2—peripheral nervous system neoplasm	0.000382	0.00281	CbGpPWpGaD
Testosterone Propionate—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000381	0.000522	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00038	0.00052	CcSEcCtD
Testosterone Propionate—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000378	0.000517	CcSEcCtD
Testosterone Propionate—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000375	0.000513	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000371	0.00273	CbGpPWpGaD
Testosterone Propionate—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00037	0.000506	CcSEcCtD
Testosterone Propionate—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000367	0.000502	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000367	0.000502	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000361	0.00266	CbGpPWpGaD
Testosterone Propionate—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00036	0.000492	CcSEcCtD
Testosterone Propionate—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000491	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000359	0.00264	CbGpPWpGaD
Testosterone Propionate—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000356	0.000487	CcSEcCtD
Testosterone Propionate—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000354	0.000484	CcSEcCtD
Testosterone Propionate—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000354	0.000484	CcSEcCtD
Testosterone Propionate—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000353	0.000483	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.000481	CcSEcCtD
Testosterone Propionate—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.000478	CcSEcCtD
Testosterone Propionate—Progesterone—ABCB1—peripheral nervous system neoplasm	0.000345	0.0612	CrCbGaD
Testosterone Propionate—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.000468	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.000464	CcSEcCtD
Testosterone Propionate—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.000464	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000339	0.00249	CbGpPWpGaD
Testosterone Propionate—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000334	0.000457	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.000455	CcSEcCtD
Testosterone Propionate—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000332	0.000454	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	0.00033	0.00243	CbGpPWpGaD
Testosterone Propionate—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.000451	CcSEcCtD
Testosterone Propionate—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000329	0.000451	CcSEcCtD
Testosterone Propionate—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000327	0.000447	CcSEcCtD
Testosterone Propionate—Testosterone—ABCB1—peripheral nervous system neoplasm	0.000326	0.0579	CrCbGaD
Testosterone Propionate—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000433	CcSEcCtD
Testosterone Propionate—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000433	CcSEcCtD
Testosterone Propionate—Pain—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000429	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.000423	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000307	0.00226	CbGpPWpGaD
Testosterone Propionate—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.00042	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—AKT1—peripheral nervous system neoplasm	0.000306	0.00226	CbGpPWpGaD
Testosterone Propionate—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000417	CcSEcCtD
Testosterone Propionate—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000414	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000413	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.0003	0.00041	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.000401	CcSEcCtD
Testosterone Propionate—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.0004	CcSEcCtD
Testosterone Propionate—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000399	CcSEcCtD
Testosterone Propionate—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.000397	CcSEcCtD
Testosterone Propionate—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00029	0.000397	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	0.00029	0.00213	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000383	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.00038	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00027	0.00037	CcSEcCtD
Testosterone Propionate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.000369	CcSEcCtD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000269	0.00198	CbGpPWpGaD
Testosterone Propionate—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.000367	CcSEcCtD
Testosterone Propionate—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000263	0.00036	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—ENO2—peripheral nervous system neoplasm	0.000262	0.00193	CbGpPWpGaD
Testosterone Propionate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000355	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—GNS—peripheral nervous system neoplasm	0.000259	0.00191	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000343	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000251	0.00185	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000342	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—NME1—peripheral nervous system neoplasm	0.000249	0.00183	CbGpPWpGaD
Testosterone Propionate—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000333	CcSEcCtD
Testosterone Propionate—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000332	CcSEcCtD
Testosterone Propionate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000328	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.00024	0.00177	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—COX2—peripheral nervous system neoplasm	0.000239	0.00176	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000238	0.00175	CbGpPWpGaD
Testosterone Propionate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000319	CcSEcCtD
Testosterone Propionate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000318	CcSEcCtD
Testosterone Propionate—Rash—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000316	CcSEcCtD
Testosterone Propionate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000316	CcSEcCtD
Testosterone Propionate—Headache—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000314	CcSEcCtD
Testosterone Propionate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000307	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—BCHE—peripheral nervous system neoplasm	0.000221	0.00163	CbGpPWpGaD
Testosterone Propionate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000298	CcSEcCtD
Testosterone Propionate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000295	CcSEcCtD
Testosterone Propionate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000293	CcSEcCtD
Testosterone Propionate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000292	CcSEcCtD
Testosterone Propionate—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000291	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000212	0.00156	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000211	0.00156	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—TH—peripheral nervous system neoplasm	0.000208	0.00153	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000206	0.00152	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000202	0.00149	CbGpPWpGaD
Testosterone Propionate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000276	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000201	0.00148	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—TH—peripheral nervous system neoplasm	0.000199	0.00147	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000197	0.00145	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GNAS—peripheral nervous system neoplasm	0.00017	0.00125	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000167	0.00123	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000166	0.00122	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000163	0.0012	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.00016	0.00118	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000157	0.00116	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000133	0.000977	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000127	0.000932	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—TH—peripheral nervous system neoplasm	0.000125	0.000918	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	0.000119	0.000877	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000102	0.00075	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	9.99e-05	0.000736	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—MYC—peripheral nervous system neoplasm	5.74e-05	0.000422	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—AKT1—peripheral nervous system neoplasm	4.59e-05	0.000338	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—AKT1—peripheral nervous system neoplasm	4.39e-05	0.000323	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—AKT1—peripheral nervous system neoplasm	3.98e-05	0.000293	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.75e-05	0.000202	CbGpPWpGaD
